Viral Vector Platforms – Accelerating Timelines To Manufacturing & Commercialization

Time: 1:00 pm
day: Day One

Details:

• Besides usual challenges such as specificity of delivery, control of activity, and immunogenicity, gene therapy developers encounter hurdles associated with manufacturing and scale-up, product analysis, and limited skilled workforce

• FUJIFILM Diosynth Biotechnologies provides a flexible viral vector development and manufacturing platform

• This presentation will focus on strategic considerations that can help our partners navigate these challenges by streamlining the critical path from pre-clinical and clinical development through commercialization

Speakers: